Effect of dialysis duration on serum calcium and phosphorous in hemodialysis patients

Chronic renal insufficiency is associated with changes in mineral and bone metabolism biochemistry and density.2,3 In many countries, physicians follow clinical guidelines for mineral bone disorders to control secondary hyperparathyroidism associated with serum calcium and phosphorous level in patients maintaining hemodialysis (HD).1 With the begin of hemodialysis, histological marks of secondary hyperparathyroidism could be seen in bones of over 50 percent4 of end stage renal disease (ESRD) patients, skeletal defects identified as Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) (the so called as renal osteodystrophy) consist of some types of bone tissue lesions, such as the most widespread high bone turn-over disease but also the a dynamic bone disease.5,6

[1]  N. Yamamoto.  [Morphological analysis of bone dynamics and metabolic bone disease. Bone histomorphometry : the basic methods and role of bone research and clinical significance]. , 2011, Clinical calcium.

[2]  N. Yamamoto.  [Morphological analysis of bone dynamics and metabolic bone disease. Bone Histomorphometry in CKD-MBD (chronic kidney disease mineral bone disorder)]. , 2011, Clinical calcium.

[3]  E. Diamanti-Kandarakis,et al.  Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients , 2008, Journal of Bone and Mineral Metabolism.

[4]  W. Medawar,et al.  Predictors of bone mineral density in patients on hemodialysis. , 2004, Transplantation proceedings.

[5]  C. Baudoin,et al.  Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  J. Zanchetta,et al.  [Estimation of the prevalence of low turn over renal osteodystrophy using biological markers in a peritoneal dialysis population]. , 2001, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[7]  M. Taal,et al.  Risk factors for reduced bone density in haemodialysis patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  K. Atsumi,et al.  Risk factors for vertebral fractures in renal osteodystrophy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Y. Pei,et al.  The spectrum of bone disease in end-stage renal failure--an evolving disorder. , 1993, Kidney international.

[10]  E. Grapsa,et al.  Bone mineral density and bone metabolism in hemodialysis patients. Correlation with PTH, 25OHD3 and leptin. , 2012, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[11]  M. de Vernejoul,et al.  Bone histomorphometry in hemodialysed patients. , 1981, Metabolic bone disease & related research.